Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOX | P28300 | 1/20 | 0.42 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | CSNK2A1 | P68400 | 6/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.37 |
| ▸ | PNMT | P11086 | 2/20 | 0.35 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30116758 | 1.00 | LOX (0.42) | LOXLOXL3LOXL2CSNK2A1ALDH1A1 | |
| SCHEMBL2420113 | 0.83 | TAAR1 (0.50) | LOXL2ALDH1A1NPSR1PNMTTAAR1 | |
| SCHEMBL8292362 | 0.80 | CPB2 (0.47) | LOXLOXL3LOXL2CSNK2A1PNMT | |
| SCHEMBL30833526 | 0.79 | ALDH1A1 (0.42) | ALDH1A1NPSR1 | |
| SCHEMBL1141323 | 0.79 | ALDH1A1 (0.42) | ALDH1A1NPSR1 | |
| SCHEMBL1912373 | 0.78 | LOXL2 (0.39) | LOXLOXL3LOXL2PNMT | |
| SCHEMBL19835322 | 0.78 | CYP11B1 (0.50) | LOXLOXL3LOXL2ALDH1A1 | |
| SCHEMBL1912301 | 0.78 | LOX (0.39) | LOXLOXL3LOXL2CSNK2A1PNMT | |
| Hydrochloric Acid SCHEMBL5482422 | 0.78 | CPB2 (0.46) | LOXLOXL3LOXL2CSNK2A1PNMT | |
| SCHEMBL8272903 | 0.77 | ALDH1A1 (0.44) | ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230225323-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | PHILIP MORRIS PRODUCTS S.A. (CH) | 2023-07-20 | — | — | US | disclosed |
| US-20230225323-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | PHILIP MORRIS PRODUCTS S.A. (CH) | 2023-07-20 | — | — | US | disclosed |
| WO-2021260029-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | PHILIP MORRIS PRODUCTS S.A. (CH) | 2021-12-30 | — | — | WO | disclosed |
| WO-2015098991-A1 | N-ALKYLAMIDE DERIVATIVE AND MEDICINAL USE THEREOF | 東レ株式会社 | 2015-07-02 | — | — | WO | disclosed |
| US-5442072-A | Process for preparing chloromethylpyridines | BAYER AKTIENGESELLSCHAFT (DE) | 1995-08-15 | — | — | US | disclosed |
| EP-0632025-A1 | Process for the preparation of chloromethylpyridines | BAYER AG (DE) | 1995-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230225323-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | TRHDE, CUTA, PIGS | LOX 194/4885LOXL3 1703/4885LOXL2 930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.